red yeast
Botanicalexperimental
Clinical trial activity
6 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
3
Earliest trial started Jul 1, 2014 (NCT02422927)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS1EU532DCW4 ↗
Also known as
- chinese red yeast rice
- hypocol
- red yeast
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06333158 | Phase 4 | Mar 1, 2024 | University of Antwerp |
| NCT04874961 | Phase 4 | May 20, 2021 | University of Antwerp, ZNA Antwerpen |
| NCT04846231 | Phase 2 | Apr 23, 2021 | AstraZeneca, The Cleveland Clinic |
| NCT03739242 | N/A | Oct 12, 2017 | Menarini Group, University of Bologna |
| NCT02142569 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2015 | University of California, Los Angeles |
| NCT02422927 | Phase 4 | Jul 1, 2014 | University of Perugia |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Antwerp | Academic/Hospital | 2 | 1 | 1 | 2021 |
| AstraZeneca | For profit | 1 | 0 | 1 | 2021 |
| Menarini Group | For profit | 1 | 1 | 1 | 2017 |
| The Cleveland Clinic | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Bologna | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Perugia | Academic/Hospital | 1 | 1 | 1 | 2014 |
| ZNA Antwerpen | Academic/Hospital | 1 | 1 | 1 | 2021 |
8 organizations
Page 1 / 1